Stockreport

Hinge Bio Presents Preclinical Data from its GEM-DIMER Program Targeting B Cell Depletion at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF BURLINGAME, Calif. April 8, 2024 /PRNewswire/ -- Hinge Bio, Inc., a privately-held biotechnology company, today announced that Daniel Capon , Ph.D., Chief Scientific Of [Read more]